Thu, March 8, 2012
Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC

Watson to Present at the Barclays Capital 2012 Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. s-capital-2012-global-healthcare-conference.html
Published in Health and Fitness on Thursday, March 1st 2012 at 13:17 GMT by Market Wire   Print publication without navigation


Watson to Present at the Barclays Capital 2012 Global Healthcare Conference -- PARSIPPANY, N.J., March 1, 2012 /PRNewswire/ --

Watson to Present at the Barclays Capital 2012 Global Healthcare Conference

[ ]

PARSIPPANY, N.J., March 1, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: [ WPI ]), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Barclays Capital 2012 Global Healthcare Conference on Tuesday, March 13, 2012 at 8:30 am Eastern Time at the Loews Miami Hotel in Miami, Florida.  The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at [ http://ir.watson.com ].  The webcast can also be accessed at the following URL:

[ http://cc.talkpoint.com/barc002/031312a_lp/?entity=5_YSGJ7G2 ]

An archived version will be available by the next day after the live presentation and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at [ http://www.watson.com ].

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

CONTACTS:

Investors:

 

Patty Eisenhaur

 

(862) 261-8141

 

 

 

Media:

 

Charlie Mayr

 

(862) 261-8030

(Logo: [ http://photos.prnewswire.com/prnh/20100121/LA41294LOGO ] )

SOURCE Watson Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.watson.com ]


Publication Contributing Sources